Gilman Hill Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
– Sell
-7,725
Closed -$329K – 189
2015
Q4
$329K Sell
7,725
-1,500
-16% -$69K 0.16% 119
2015
Q3
$438K Hold
9,225
– – 0.23% 88
2015
Q2
$457K Sell
9,225
-250
-3% -$12.7K 0.22% 94
2015
Q1
$468K Sell
9,475
-41
-0.4% -$1.96K 0.22% 88
2014
Q4
$434K Buy
9,516
+250
+3% +$12.1K 0.22% 93
2014
Q3
$523K Sell
9,266
-250
-3% -$13.4K 0.28% 78
2014
Q2
$506K Hold
9,516
– – 0.26% 79
2014
Q1
$497K Buy
9,516
+5,000
+111% +$253K 0.29% 73
2013
Q4
$242K Buy
+4,516
New +$233K 0.16% 98
2013
Q3
– Sell
-6,933
Closed -$357K – 115
2013
Q2
$357K Buy
+6,933
New +$369K 0.26% 72

Other funds holding SNY

Gilman Hill Asset Management's SNY Position: Q1 2016 in Review

Gilman Hill Asset Management sold out of Sanofi (SNY) in Q1 2016, closing a stake of 7,725 shares — an estimated $329K sold.

Gilman Hill Asset Management first reported a position in SNY in Q2 2013 and held it in 10 quarters. The position peaked at $523K in Q3 2014. 449 funds tracked by Wall St. Rank hold SNY as of Q1 2016.

  • Gilman Hill Asset Management reported no remaining Sanofi position as of Q1 2016 after selling out during the quarter.
  • Gilman Hill Asset Management sold 7,725 Sanofi shares in Q1 2016, an estimated $329K.
  • Gilman Hill Asset Management first reported a position in Sanofi in Q2 2013 and held it in 10 quarters.
  • Gilman Hill Asset Management's Sanofi position peaked at $523K in Q3 2014.
  • 449 funds tracked by Wall St. Rank held Sanofi as of Q1 2016.

Based on Gilman Hill Asset Management's 13F filing for Q1 2016, filed 6 May 2016.